| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.09 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.085 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.05 | 0.4 |